Corrigendum: Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential

• Thomas Rossetti,
• Jacob Ferreira,
• Lubna Ghanem,
• Hannes Buck,
• Clemens Steegborn,
• Robert W. Myers,
• Peter T. Meinke,
• Lonny R. Levin,
• Jochen Buck

Affiliations

Thomas Rossetti

Department of Pharmacology, Weill Cornell Medicine, New York, NY, United States

Jacob Ferreira

Department of Pharmacology, Weill Cornell Medicine, New York, NY, United States

Lubna Ghanem

Department of Pharmacology, Weill Cornell Medicine, New York, NY, United States

Hannes Buck

Department of Pharmacology, Weill Cornell Medicine, New York, NY, United States

Clemens Steegborn

Department of Biochemistry, University of Bayreuth, Bayreuth, Germany

Robert W. Myers

Tri-Institutional Therapeutics Discovery Institute, New York, NY, United States

Peter T. Meinke

Tri-Institutional Therapeutics Discovery Institute, New York, NY, United States

Lonny R. Levin

Department of Pharmacology, Weill Cornell Medicine, New York, NY, United States

Jochen Buck

Department of Pharmacology, Weill Cornell Medicine, New York, NY, United States